The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.730
+0.060 (1.63%)
At close: Aug 1, 2025, 4:00 PM
3.790
+0.060 (1.61%)
After-hours: Aug 1, 2025, 7:34 PM EDT

Accolade Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Accolade stock has a target of 6.00, which predicts a 60.86% increase from the current stock price of 3.73.

Price Target: $6.00 (+60.86%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$6.00$6.00$6.00$6.00
Change+60.86%+60.86%+60.86%+60.86%

Analyst Ratings

According to 1 stock analyst, the rating for Accolade is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy222211
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$6
Strong BuyInitiates$6+60.86%Jul 16, 2025
Jefferies
Jefferies
Strong Buy
Initiates
$2.5
Strong BuyInitiates$2.5-32.98%Feb 26, 2024
Guggenheim
Guggenheim
Strong Buy
Maintains
$3$2
Strong BuyMaintains$3$2-46.38%Jun 16, 2023
Guggenheim
Guggenheim
Hold
Maintains
$6$3
HoldMaintains$6$3-19.57%Mar 20, 2023
Guggenheim
Guggenheim
Strong Buy
Maintains
$7$6
Strong BuyMaintains$7$6+60.86%Nov 11, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
469.75M
from 393.41M
Increased by 19.40%
Revenue Next Year
n/a
from 469.75M
EPS This Year
-0.16
from -0.71
EPS Next Year
n/a
from -0.16
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue
187.52M203.00M252.48M324.24M393.41M469.75M
Revenue Growth
20.66%8.26%24.37%28.42%21.33%19.40%
EPS
-0.24-0.16-0.21-0.92-0.71-0.16
EPS Growth
------
Forward PE
------
No. Analysts
-----2
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025
High491.5M
Avg469.8M
Low452.9M

Revenue Growth

Revenue Growth2025
High
24.9%
Avg
19.4%
Low
15.1%

EPS Forecast

EPS2025
High-0.17
Avg-0.16
Low-0.16

EPS Growth

EPS Growth2025
High-
Avg-
Low-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.